Kampmann Melissa S. Trims Stock Holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Kampmann Melissa S. reduced its stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 8.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 23,925 shares of the company’s stock after selling 2,190 shares during the period. Kampmann Melissa S. owned approximately 0.08% of iRhythm Technologies worth $2,157,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of IRTC. Eventide Asset Management LLC raised its holdings in iRhythm Technologies by 170.8% in the 3rd quarter. Eventide Asset Management LLC now owns 736,721 shares of the company’s stock valued at $54,694,000 after buying an additional 464,629 shares during the period. Braidwell LP raised its holdings in iRhythm Technologies by 48.7% in the 3rd quarter. Braidwell LP now owns 782,557 shares of the company’s stock valued at $58,097,000 after buying an additional 256,200 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in iRhythm Technologies by 38.1% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 707,175 shares of the company’s stock valued at $52,501,000 after buying an additional 195,246 shares during the period. Stephens Investment Management Group LLC raised its holdings in iRhythm Technologies by 25.6% in the 4th quarter. Stephens Investment Management Group LLC now owns 502,925 shares of the company’s stock valued at $45,349,000 after buying an additional 102,600 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in iRhythm Technologies in the 4th quarter valued at about $9,151,000.

Wall Street Analyst Weigh In

IRTC has been the topic of several research analyst reports. Canaccord Genuity Group boosted their price objective on shares of iRhythm Technologies from $125.00 to $152.00 and gave the company a “buy” rating in a report on Monday, December 9th. Wells Fargo & Company boosted their price target on shares of iRhythm Technologies from $86.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Friday, February 21st. StockNews.com upgraded shares of iRhythm Technologies from a “sell” rating to a “hold” rating in a research note on Monday, February 24th. Truist Financial boosted their price target on shares of iRhythm Technologies from $111.00 to $145.00 and gave the stock a “buy” rating in a research note on Friday, February 21st. Finally, Oppenheimer boosted their price target on shares of iRhythm Technologies from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 8th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $119.73.

iRhythm Technologies Stock Up 1.4 %

IRTC stock opened at $103.11 on Thursday. The company’s 50 day moving average price is $107.40 and its 200 day moving average price is $88.28. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.12 and a current ratio of 6.27. iRhythm Technologies, Inc. has a fifty-two week low of $55.92 and a fifty-two week high of $128.52. The firm has a market capitalization of $3.24 billion, a price-to-earnings ratio of -28.33 and a beta of 1.36.

iRhythm Technologies (NASDAQ:IRTC) last released its earnings results on Thursday, February 20th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.30. The firm had revenue of $164.33 million for the quarter, compared to analyst estimates of $158.30 million. iRhythm Technologies had a negative net margin of 19.14% and a negative return on equity of 118.83%. On average, equities research analysts anticipate that iRhythm Technologies, Inc. will post -1.98 EPS for the current fiscal year.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.